Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

ישראלמגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Schizophrenia · Bipolar I Disorder · Major Depressive Disorder

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Mapi Pharma Investigational Site IN-101, Ahmedabad, India
Contact: Study coordinator (Clinical Research Center)
Mapi Pharma Investigational Site IN-102, Ahmedabad, India
Contact: Study coordinator (Clinical Research Center)
Mapi Pharma Investigational Site IL-004, Beersheba, Israel
Contact: Study coordinator (Clinical Research Center)
Mapi Pharma Investigational Site IL-003, Ness Ziona, Israel
Contact: Study coordinator (Clinical Research Center)
Mapi Pharma Investigational Site IL-005, Ramat Gan, Israel
Contact: Study coordinator (Clinical Research Center)
Mapi Pharma Investigational Site IL-001, Tel Aviv, Israel
Contact: Study coordinator (Clinical Research Center)